Ketamine for Social Anxiety Disorder: A Randomized, Placebo-Controlled Crossover Trial

Many patients with social anxiety disorder (SAD) experience inadequate symptom relief from available treatments. Ketamine is a potent N-methyl-D-aspartate receptor antagonist with a potentially novel mechanism of action for the treatment of anxiety disorders. Therefore, we conducted a double-blind,...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Neuropsychopharmacology
Principais autores: Taylor, Jerome H, Landeros-Weisenberger, Angeli, Coughlin, Catherine, Mulqueen, Jilian, Johnson, Jessica A, Gabriel, Daniel, Reed, Margot O, Jakubovski, Ewgeni, Bloch, Michael H
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2018
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5729569/
https://ncbi.nlm.nih.gov/pubmed/28849779
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/npp.2017.194
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados